Vitamin B12 Deficiency: Supplements, Absorption, and Drug Interactions

1. Why B12 Matters

Vitamin B12 (cobalamin) is a water-soluble vitamin with an outsized role in human physiology. It is the largest and most structurally complex of all the vitamins, and it is one of only two vitamins that the human body cannot produce on its own (the other being vitamin D, which is technically a hormone). Every cell in your body needs B12, but certain systems depend on it more heavily than others.

Nervous System Maintenance

B12 is required for the synthesis and maintenance of myelin, the fatty sheath that insulates nerve fibers and allows electrical signals to travel efficiently between the brain and the rest of the body. When B12 levels are insufficient, myelin production slows and existing myelin can begin to deteriorate. This process, called demyelination, leads to symptoms like tingling and numbness in the hands and feet (peripheral neuropathy), difficulty with balance and coordination, and in severe cases, cognitive changes including memory problems and confusion. A 2003 review in the New England Journal of Medicine noted that neurological damage from B12 deficiency can become irreversible if left untreated for too long, which is why early detection matters so much.

DNA Synthesis

B12 serves as a cofactor for the enzyme methionine synthase, which converts homocysteine to methionine. This reaction is essential for producing S-adenosylmethionine (SAMe), the body's primary methyl donor. Methylation reactions driven by SAMe are involved in DNA synthesis, gene expression, neurotransmitter production, and detoxification processes. When B12 is low, this entire methylation cycle slows down, with ripple effects across multiple organ systems.

Red Blood Cell Production

B12 is also a cofactor for proper red blood cell maturation in the bone marrow. Without enough B12, red blood cells develop abnormally, becoming oversized and oval-shaped rather than the normal biconcave disc shape. These megaloblastic red cells are less efficient at carrying oxygen and have shorter lifespans, leading to a form of anemia called megaloblastic anemia. Symptoms include fatigue, weakness, shortness of breath, and pale or yellowish skin. A complete blood count (CBC) showing elevated mean corpuscular volume (MCV) is often one of the first clues that a B12 problem may be developing.

Energy Metabolism

B12 is a cofactor for methylmalonyl-CoA mutase, an enzyme in the mitochondrial pathway that converts certain fatty acids and amino acids into succinyl-CoA, which feeds into the citric acid cycle for energy production. When B12 is deficient, methylmalonic acid (MMA) accumulates because this conversion stalls. This is why many people with B12 deficiency report persistent fatigue and low energy even when their red blood cell counts are still within the normal range. The fatigue often predates the anemia by months or even years.

2. Who Is at Risk for Deficiency

B12 deficiency is more common than most people realize. National Health and Nutrition Examination Survey (NHANES) data suggest that roughly 3 to 4% of the general U.S. adult population has frankly low B12 levels, with another 15 to 20% in a "gray zone" where levels may be suboptimal. Certain groups face substantially higher risk.

Vegans and Vegetarians

B12 is found naturally only in animal-derived foods: meat, fish, eggs, and dairy. There are no reliable plant-based sources unless they have been fortified. A 2013 systematic review in theEuropean Journal of Clinical Nutrition found that up to 86% of vegans and 33% of lacto-ovo vegetarians had serum B12 levels below 200 pg/mL when not supplementing. This makes B12 supplementation essentially non-negotiable for anyone following a fully plant-based diet.

Older Adults With Reduced Intrinsic Factor

Absorbing B12 from food is a multi-step process that requires adequate stomach acid, a protein called intrinsic factor (produced by parietal cells in the stomach lining), and healthy receptors in the terminal ileum. As people age, the stomach lining gradually atrophies in a condition called atrophic gastritis, which reduces both acid production and intrinsic factor secretion. Studies estimate that 10 to 30% of adults over age 60 have some degree of atrophic gastritis, placing them at significant risk for B12 malabsorption even with adequate dietary intake. The National Academy of Medicine (formerly the Institute of Medicine) specifically recommends that adults over 50 get most of their B12 from supplements or fortified foods rather than relying solely on dietary sources.

Metformin Users

Metformin, the most widely prescribed medication for type 2 diabetes worldwide, is a well-documented cause of B12 deficiency. This connection is significant enough that it warrants its own section later in this article. In brief, long-term metformin use reduces B12 absorption in the ileum, and the risk increases with dose and duration.

PPI and H2 Blocker Users

Proton pump inhibitors (such as omeprazole, esomeprazole, lansoprazole, and pantoprazole) and H2 receptor blockers (such as famotidine and ranitidine) reduce stomach acid production. Since acid is needed to release B12 from the proteins it is bound to in food, prolonged use of these medications can lead to gradual B12 depletion. This interaction is discussed in detail in its own section below.

Post-Bariatric Surgery Patients

Gastric bypass surgery and other bariatric procedures alter the anatomy of the stomach and small intestine, often bypassing or reducing the areas where intrinsic factor is produced and where B12 is absorbed. B12 deficiency rates after Roux-en-Y gastric bypass can reach 30 to 75% within a few years if patients are not supplementing. Lifelong B12 monitoring and supplementation (often via injection or high-dose sublingual) is considered standard of care for post-bariatric patients.

3. B12 Supplement Forms Compared

Walk into a supplement aisle and you will find B12 sold in several different forms. Each has a different chemical structure, a different metabolic pathway in the body, and different practical characteristics worth considering.

Cyanocobalamin

This is the most common and least expensive form of supplemental B12. It is a synthetic molecule that does not occur in nature. The body must convert cyanocobalamin into its active forms (methylcobalamin and adenosylcobalamin) through a multi-step process that involves removing the cyanide group and attaching a methyl or adenosyl group instead. The amount of cyanide released is extremely small and toxicologically insignificant in healthy individuals. Cyanocobalamin has the longest track record in clinical research and is the form used in most large-scale studies on B12 supplementation. It is also the most shelf-stable form, retaining potency longer than the bioactive forms.

Methylcobalamin

Methylcobalamin is one of the two bioactive coenzyme forms of B12. It serves as the cofactor for methionine synthase in the cytoplasm, the enzyme responsible for converting homocysteine to methionine. Because it is already in its active form, methylcobalamin does not require the conversion steps that cyanocobalamin does. Some practitioners prefer it for patients with genetic variations in the MTHFR gene that may affect methylation pathways, though the clinical evidence for this preference remains limited. Methylcobalamin is less stable than cyanocobalamin and is sensitive to light, which means it can degrade more quickly if not stored properly.

Hydroxocobalamin

Hydroxocobalamin is the form of B12 produced by bacteria in the gut (though humans absorb very little of what gut bacteria produce, since it is made in the colon, downstream of the absorption site in the ileum). It is the preferred form for intramuscular B12 injections in many countries, particularly in Europe, because it binds more tightly to transport proteins in the blood and is retained in the body significantly longer than cyanocobalamin. A single intramuscular injection of hydroxocobalamin can maintain adequate B12 levels for 2 to 3 months, compared to roughly 4 to 6 weeks for cyanocobalamin. Hydroxocobalamin is also the antidote for cyanide poisoning, administered intravenously at very high doses.

Adenosylcobalamin

Adenosylcobalamin (also called dibencozide or cobamamide) is the other bioactive coenzyme form of B12. It functions in the mitochondria as the cofactor for methylmalonyl-CoA mutase, the enzyme that converts methylmalonyl-CoA to succinyl-CoA in the energy production pathway. Adenosylcobalamin supplements are less commonly available than the other forms and tend to be more expensive. Some combination supplements provide both methylcobalamin and adenosylcobalamin to cover both of B12's coenzyme roles, though there is no strong clinical evidence that this combination outperforms cyanocobalamin or methylcobalamin alone for most people.

4. The Metformin-B12 Connection

The link between metformin and vitamin B12 deficiency is one of the most well-established drug-nutrient interactions in medicine, yet it remains underappreciated in everyday clinical practice. A landmark randomized controlled trial published in the British Medical Journal(BMJ) in 2010 by de Jager and colleagues followed metformin users over 4.3 years and found that metformin treatment was associated with a 19% decrease in B12 levels compared to placebo, with 7.2% of metformin-treated patients developing frank deficiency versus 2.3% in the placebo group.

Estimates across multiple studies suggest that 10 to 30% of long-term metformin usersdevelop some degree of B12 deficiency, with the risk climbing as the dose increases and the duration of use extends. A 2016 meta-analysis in the Journal of Clinical Endocrinology and Metabolism confirmed the dose-dependent relationship: higher metformin doses correlated with greater B12 reduction.

The mechanism behind this interaction is fascinating and distinct from how most drugs interfere with nutrient absorption. B12 absorption in the terminal ileum depends on the intrinsic factor-B12 complex binding to receptors called cubam (cubilin-amnionless). This binding step is calcium-dependent. Metformin appears to interfere with this process by altering the calcium-dependent membrane action in ileal cells. Some researchers have proposed that metformin affects intracellular calcium availability, while others suggest it may disrupt the endocytic uptake of the intrinsic factor-B12 complex.

An interesting finding from a 2000 study by Bauman and colleagues, published inDiabetes Care, showed that calcium supplementation could partially reverse the metformin-induced reduction in B12 absorption. While this does not mean that everyone on metformin should start taking calcium, it does support the mechanistic hypothesis that calcium plays a central role in this interaction.

Current guidelines from the American Diabetes Association (ADA) recommend periodic B12 monitoring in patients on long-term metformin therapy, particularly those with anemia or peripheral neuropathy. Many endocrinologists now suggest checking B12 levels annually in metformin users and supplementing proactively when levels fall below optimal ranges.

5. PPI and H2 Blocker Interactions

Proton pump inhibitors and H2 receptor blockers work by reducing the production of hydrochloric acid in the stomach. PPIs (omeprazole, esomeprazole, lansoprazole, pantoprazole, rabeprazole) are potent acid suppressors that can reduce gastric acid secretion by up to 90 to 95%. H2 blockers (famotidine, cimetidine) are somewhat less potent but still substantially reduce acid output.

The connection to B12 lies in the very first step of B12 absorption. When you eat foods containing B12, the vitamin is bound to proteins in the food. Stomach acid and the enzyme pepsin are needed to cleave B12 from these food proteins so that it can then bind to R-protein (haptocorrin) in the stomach and subsequently transfer to intrinsic factor in the small intestine. When acid production is suppressed, this initial release step is impaired, and a significant fraction of dietary B12 passes through the gut unabsorbed.

A large observational study published in the Journal of the American Medical Association(JAMA) in 2013 by Lam and colleagues examined over 25,000 patients with B12 deficiency and found that PPI use for two or more years was associated with a 65% increased risk of B12 deficiency. H2 blocker use for two or more years was associated with a 25% increased risk. The risk was higher with higher PPI doses.

One important nuance: PPIs and H2 blockers primarily affect absorption of food-bound B12. They have much less impact on the absorption of crystalline (free) B12, the form found in supplements and fortified foods. This is because supplemental B12 is not protein-bound and does not require acid for release. This means that people on long-term acid suppression therapy can often maintain adequate B12 status simply by taking a B12 supplement, even at relatively modest doses.

6. Colchicine and Chloramphenicol Interactions

Colchicine

Colchicine, used primarily for gout flares and familial Mediterranean fever, can reduce the absorption of vitamin B12 from the gastrointestinal tract. The mechanism involves disruption of the function of ileal mucosal cells, where B12 absorption takes place. Colchicine interferes with microtubule function within these cells, which can impair the endocytosis of the intrinsic factor-B12 complex. While clinically significant B12 deficiency from colchicine alone is relatively uncommon at standard doses, the risk increases with chronic use and in individuals who already have borderline B12 status or other risk factors for deficiency. People on long-term colchicine therapy may benefit from periodic B12 monitoring.

Chloramphenicol

Chloramphenicol is a broad-spectrum antibiotic that is used less frequently today than in past decades, but it still sees clinical use in certain infections (particularly eye infections and in resource-limited settings). Chloramphenicol can interfere with the hematological response to B12 supplementation rather than with B12 absorption itself. It does this by suppressing red blood cell production in the bone marrow. In patients being treated for B12 deficiency anemia, concurrent chloramphenicol use can blunt the expected reticulocyte response and slow recovery of red blood cell counts. If a patient on B12 supplementation is not responding as expected, concurrent chloramphenicol use should be considered as a possible contributing factor.

7. Testing and Optimal Levels

Testing for B12 status is more nuanced than most people realize. No single test captures the full picture, and relying solely on serum B12 can be misleading.

Serum B12

This is the most commonly ordered test. It measures total B12 in the blood, including both active and inactive forms. Most laboratories define the reference range as approximately 200 to 900 pg/mL (148 to 664 pmol/L). Values below 200 pg/mL are generally considered deficient, while values between 200 and 300 pg/mL fall into a gray zone where deficiency is possible even though the number appears "normal." Many functional medicine practitioners and some hematologists consider levels below 400 to 500 pg/mL to be suboptimal, particularly in patients with neurological symptoms.

Methylmalonic Acid (MMA)

MMA is considered a more sensitive and specific marker for functional B12 deficiency than serum B12 alone. When B12 is insufficient, the enzyme methylmalonyl-CoA mutase cannot function properly, and MMA accumulates in the blood. Elevated MMA (above approximately 0.4 micromol/L, though reference ranges vary by lab) in the presence of normal or borderline serum B12 strongly suggests tissue-level B12 insufficiency. MMA testing is particularly useful for catching early or subclinical deficiency before it progresses to anemia or neurological symptoms.

Homocysteine

Homocysteine levels rise when B12 is deficient because the B12-dependent conversion of homocysteine to methionine slows down. However, elevated homocysteine is not specific to B12 deficiency. It can also be caused by folate deficiency, vitamin B6 deficiency, kidney impairment, hypothyroidism, and genetic factors. An elevated homocysteine combined with elevated MMA is a strong indicator of B12 deficiency specifically, while elevated homocysteine with normal MMA points more toward folate deficiency.

For people on metformin, PPIs, or other medications that increase deficiency risk, checking serum B12 along with MMA at least once a year provides a much clearer picture than serum B12 alone. If neurological symptoms are present, testing should not be delayed regardless of what the serum B12 level shows.

8. Sublingual vs. Injection vs. Oral Supplements

There are three main ways to deliver supplemental B12, and each has a role depending on the clinical situation.

Oral Supplements

Standard oral B12 supplements are swallowed and absorbed through the normal gastrointestinal pathway. For people with intact absorption (no intrinsic factor issues, no ileal disease, no gastric surgery), oral supplements at standard doses (250 to 1000 mcg daily) work well for maintaining adequate levels and correcting mild deficiency. The absorption of oral B12 occurs through two mechanisms: the intrinsic factor-mediated pathway (which is saturable, handling about 1.5 to 2 mcg per meal) and passive diffusion across the intestinal wall (which is non-saturable but very inefficient, absorbing roughly 1 to 2% of the oral dose). This passive diffusion pathway is why high-dose oral B12 (1000 to 2000 mcg daily) can still deliver meaningful amounts even in people with impaired intrinsic factor function.

Sublingual Supplements

Sublingual B12 tablets or drops dissolve under the tongue and are absorbed through the oral mucosa directly into the bloodstream, bypassing the gastrointestinal tract. This route is often marketed as superior to standard oral supplements, and it has theoretical advantages for people with absorption issues. However, a 2003 study by Sharabi and colleagues published in the British Journal of Clinical Pharmacology compared sublingual and oral B12 at equivalent doses and found similar improvements in serum B12 levels in both groups. The practical difference may be modest for most people, but sublingual delivery can be a reasonable alternative for those who prefer not to receive injections and have known absorption challenges.

Intramuscular Injections

B12 injections (typically hydroxocobalamin or cyanocobalamin) bypass the entire gastrointestinal tract and deliver B12 directly into the muscle tissue, from where it is absorbed into the bloodstream. Injections are considered the gold standard for treating severe B12 deficiency, pernicious anemia (an autoimmune condition that destroys intrinsic factor-producing cells), and deficiency with neurological symptoms. A typical treatment protocol involves daily or every-other-day injections for 1 to 2 weeks, followed by weekly injections for a month, and then monthly maintenance injections. However, a growing body of evidence, including a 2018 Cochrane review, suggests that high-dose oral B12 (1000 to 2000 mcg daily) may be as effective as injections for most patients, even those with pernicious anemia, thanks to the passive diffusion absorption pathway. The choice between injection and high-dose oral supplementation often comes down to patient preference, adherence, and clinical severity.

9. Dosage Guidance

The recommended dietary allowance (RDA) for vitamin B12 in adults is 2.4 mcg per day, which reflects the amount needed to maintain adequate stores in healthy individuals with normal absorption. However, the doses used in supplementation are typically much higher because absorption efficiency is low, especially from oral supplements.

For general maintenance in people at risk of deficiency (vegans, vegetarians, adults over 50, or those on metformin or PPIs), daily doses of 250 to 500 mcg of oral B12 are commonly recommended. This provides a comfortable margin above the RDA and accounts for the limited absorption efficiency of oral supplements.

For correcting a documented deficiency, higher doses are typically used. Oral or sublingual doses of 1000 to 2000 mcg daily for 1 to 3 months are a common approach, with levels rechecked after this repletion period. If absorption is severely impaired (as in pernicious anemia or post-gastric surgery), intramuscular injections of 1000 mcg may be given on a schedule determined by the treating clinician, often starting with frequent loading doses and transitioning to monthly maintenance.

B12 is a water-soluble vitamin and has no established tolerable upper intake level (UL) because toxicity from oral supplementation has not been demonstrated even at very high doses. Excess B12 is excreted in the urine. That said, taking extremely high doses without a clinical reason is not necessary and is generally not recommended as a long-term strategy. The goal should be to achieve and maintain serum B12 levels comfortably within the optimal range (ideally above 400 to 500 pg/mL for most people) through the lowest effective dose.

10. The Folate-B12 Relationship

The relationship between folate (vitamin B9) and vitamin B12 is one of the most clinically important nutrient interactions in all of nutrition, and misunderstanding it can lead to serious harm.

Both folate and B12 are required for normal red blood cell maturation and DNA synthesis. When either nutrient is deficient, red blood cells develop abnormally, producing the characteristic megaloblastic anemia. On a blood test, folate deficiency and B12 deficiency look nearly identical: both produce macrocytic (large-cell) anemia with elevated MCV. The problem arises when someone with undiagnosed B12 deficiency takes folate supplements (or eats heavily fortified foods).

Folate supplementation can correct the anemia caused by B12 deficiency, normalizing the blood count and masking what would otherwise be an important diagnostic clue. Meanwhile, the neurological damage caused by B12 deficiency continues to progress silently in the background. By the time neurological symptoms become obvious, the damage may be partially or fully irreversible. This phenomenon is sometimes called the "masking effect" of folate on B12 deficiency, and it was one of the primary concerns raised during the debate over mandatory folic acid fortification of grain products in the United States and Canada in the late 1990s.

A 2007 study by Morris and colleagues, published in the American Journal of Clinical Nutrition, used NHANES data to examine this relationship in older adults. They found that among individuals with low B12 status, those with high folate intake had significantly worse cognitive outcomes and a higher prevalence of anemia compared to those with normal folate intake. This suggests that excess folate in the context of B12 deficiency may actually accelerate neurological decline, though the mechanism is still debated.

The practical takeaway is straightforward: anyone supplementing with folate or folic acid should ensure their B12 status is adequate. This is particularly important for older adults, vegans, metformin users, and anyone on long-term acid suppression therapy. Many B-complex supplements and prenatal vitamins include both folate and B12 together, which is a sensible approach. If you are taking a standalone folate supplement, having your B12 levels checked periodically is a wise precaution.